Malignant ascites: A 2-year review from a teaching hospital

European Journal of Surgical Oncology

Volumn 22, Issue 3, 1996, Pages 237-239

  Parsons, Simon L ^a   Lang, Martin W ^a   Steele, Robert J C ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Ascites; Gastrointestinal neoplasms; Ovarian neoplasms; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; ASCITES; CANCER SURVIVAL; CLINICAL FEATURE; DIGESTIVE SYSTEM CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVARY TUMOR; PRIORITY JOURNAL; PROGNOSIS;

EID: 0029901208     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(96)80009-6     Document Type: Article

References (10)

1. Runyon B. Care of patients with ascites. New Engl J Med 1994; 330: 337-42.
2. Appelqvist P, Silvo J, Salmeda L, Kostianien S. On the treatment and prognosis of malignant ascites; is survival time determined when the abdominal paracentesis is needed? J Surg Oncol 1982; 20: 238-42.
3. Garrison R, Kaelin L, Galloway R, Heuser L. Malignant ascites. Clinical and experimental observations. Ann Surg 1986; 203: 644-51.
4. Malik I, Abubakar S, Rizwana I, Alam F, Rizvi J, Khan A. Clinical features and management of malignant ascites. JPMA 1991; 41: 38-40.
5. Ringenberg Q, Doll D, Loy T, Yarbro J. Malignant ascites of unknown origin. Cancer 1989; 64: 753-5.
6. Richardson G, Scully R, Nikrui N, Nelson J. Common epithelial cancer of the ovary (part 2). New Engl J Med 1985; 312: 474-83.
7. Parsons SL, Watson SA, Steele RJC. Malignant ascites: a review. Br J Surg 1996; 83: 6-14.
8. Ariel I, Orepeza R, Pack G. Intracavitary administration of radioactive isotopes in the control or effusions due to cancer. Cancer 1966; 19: 1096-102.
9. Ostrowski M. An assessment of the long term results of controlling the reaccumulation of malignant effusions using intracavity Bleomycin. Cancer 1986; 57: 721-7.
10. Jackson G, Blosser N. Intracavitary chromic phosphate colloidal suspension therapy. Cancer 1981; 48: 2596-8.